Cancer52 All Members Meeting – NHS Long Term Plan and NICE Methods and Processes
The Cancer52 All Members Meeting took place on Wednesday 16th [...]
The Cancer52 All Members Meeting took place on Wednesday 16th [...]
Steve Pointon attended a workshop last week organised by National [...]
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
In this video interview with Dr Monty Pal from the [...]
The discovery of a reliable biomarker for metastatic renal cell [...]
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
In this study, 6,043 patients with metastatic renal cell carcinoma [...]
Cabozantinib and sunitinib are both drugs that block the development [...]
Most studies have shown that many cancer patients are at [...]
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]